| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A blood-based nutritional risk index explains cognitive enhancement and decline in the multidomain Alzheimer prevention trial
|
Bowman, Gene L.
|
|
|
5 |
C |
p. 953-963
|
artikel
|
| 2 |
Accelerometer-determined physical activity and cognitive function in middle-aged and older adults from two generations of the Framingham Heart Study
|
Spartano, Nicole L.
|
|
|
5 |
C |
p. 618-626
|
artikel
|
| 3 |
A genetic signature including apolipoprotein Eε4 potentiates the risk of herpes simplex–associated Alzheimer's disease
|
Lopatko Lindman, Karin
|
|
|
5 |
C |
p. 697-704
|
artikel
|
| 4 |
Aiding the discovery of new treatments for dementia by uncovering unknown benefits of existing medications
|
Kern, David M.
|
|
|
5 |
C |
p. 862-870
|
artikel
|
| 5 |
Alzheimer's disease drug development pipeline: 2019
|
Cummings, Jeffrey
|
|
|
5 |
C |
p. 272-293
|
artikel
|
| 6 |
Alzheimer's disease mechanisms in peripheral cells: Promises and challenges
|
Trushina, Eugenia
|
|
|
5 |
C |
p. 652-660
|
artikel
|
| 7 |
Alzheimer's disease medication and risk of all-cause mortality and all-cause hospitalization: A retrospective cohort study
|
Bhattacharjee, Sandipan
|
|
|
5 |
C |
p. 294-302
|
artikel
|
| 8 |
Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE-ε4/TOMM40 long poly-T repeat allele variants
|
Prokopenko, Inga
|
|
|
5 |
C |
p. 814-824
|
artikel
|
| 9 |
Alzheimer's disease progression and risk factors: A standardized comparison between six large data sets
|
Evans, Stephanie
|
|
|
5 |
C |
p. 515-523
|
artikel
|
| 10 |
Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials
|
Langlois, Carolyn M.
|
|
|
5 |
C |
p. 705-716
|
artikel
|
| 11 |
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
|
Stamate, Daniel
|
|
|
5 |
C |
p. 933-938
|
artikel
|
| 12 |
A model of lipid dysregulation and altered nutrient status in Alzheimer's disease
|
Fluegge, Keith
|
|
|
5 |
C |
p. 139-145
|
artikel
|
| 13 |
Amyloid-β oligomers suppress subunit-specific glutamate receptor increase during LTP
|
Tanaka, Hiromitsu
|
|
|
5 |
C |
p. 797-808
|
artikel
|
| 14 |
Amyloid β perturbs elevated heme flux induced with neuronal development
|
Vidal, Chantal
|
|
|
5 |
C |
p. 27-37
|
artikel
|
| 15 |
Analyses of natural courses of Japanese patients with Alzheimer's disease using placebo data from placebo-controlled, randomized clinical trials: Japanese Study on the Estimation of Clinical course of Alzheimer's disease
|
Watanabe, Mitsunori
|
|
|
5 |
C |
p. 398-408
|
artikel
|
| 16 |
Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims data
|
Chen, Yi
|
|
|
5 |
C |
p. 197-207
|
artikel
|
| 17 |
A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
|
Grundman, Michael
|
|
|
5 |
C |
p. 20-26
|
artikel
|
| 18 |
Are antidementia drugs associated with reduced mortality after a hospital emergency admission in the population with dementia aged 65 years and older?
|
Hapca, Simona
|
|
|
5 |
C |
p. 431-440
|
artikel
|
| 19 |
A roadmap to develop dementia research capacity and capability in Pakistan: A model for low- and middle-income countries
|
Leroi, Iracema
|
|
|
5 |
C |
p. 939-952
|
artikel
|
| 20 |
A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy
|
Torvell, Megan
|
|
|
5 |
C |
p. 579-591
|
artikel
|
| 21 |
Assessment of need and practice for assistive technology and telecare for people with dementia—The ATTILA (Assistive Technology and Telecare to maintain Independent Living At home for people with dementia) trial
|
Forsyth, Kirsty
|
|
|
5 |
C |
p. 420-430
|
artikel
|
| 22 |
Association between thiopurine medication exposure and Alzheimer's disease among a cohort of patients with inflammatory bowel disease
|
Sutton, S.Scott
|
|
|
5 |
C |
p. 809-813
|
artikel
|
| 23 |
Associations of hemoglobin A1c with cognition reduced for long diabetes duration
|
Silverman, Jeremy M.
|
|
|
5 |
C |
p. 926-932
|
artikel
|
| 24 |
A systematic review of the use of virtual reality and its effects on cognition in individuals with neurocognitive disorders
|
Moreno, Alexander
|
|
|
5 |
C |
p. 834-850
|
artikel
|
| 25 |
A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms
|
Bernard, Katy
|
|
|
5 |
C |
p. 231-240
|
artikel
|
| 26 |
B Sharp—The cognitive effects of a pilot community music program for people with dementia-related disorders
|
Davalos, Deana B.
|
|
|
5 |
C |
p. 592-596
|
artikel
|
| 27 |
Chinese herbal medicine Qinggongshoutao for the treatment of amnestic mild cognitive impairment: A 52-week randomized controlled trial
|
Tian, Jinzhou
|
|
|
5 |
C |
p. 441-449
|
artikel
|
| 28 |
Comparison of cholinesterase inhibitor safety in real-world practice
|
Carney, Greg
|
|
|
5 |
C |
p. 732-739
|
artikel
|
| 29 |
Convolution neural network–based Alzheimer's disease classification using hybrid enhanced independent component analysis based segmented gray matter of T2 weighted magnetic resonance imaging with clinical valuation
|
Basheera, Shaik
|
|
|
5 |
C |
p. 974-986
|
artikel
|
| 30 |
Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's disease
|
Hata, Saori
|
|
|
5 |
C |
p. 740-750
|
artikel
|
| 31 |
Diagnostic accuracy of a global cognitive screen for Māori and non-Māori octogenarians
|
Zawaly, Kristina
|
|
|
5 |
C |
p. 542-552
|
artikel
|
| 32 |
Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
|
Merluzzi, Andrew P.
|
|
|
5 |
C |
p. 129-138
|
artikel
|
| 33 |
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
|
Andrews, J. Scott
|
|
|
5 |
C |
p. 354-363
|
artikel
|
| 34 |
Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients
|
Wittenberg, Raphael
|
|
|
5 |
C |
p. 382-387
|
artikel
|
| 35 |
Effect of zerumbone on scopolamine-induced memory impairment and anxiety-like behaviours in rats
|
Jafarian, Sahba
|
|
|
5 |
C |
p. 637-643
|
artikel
|
| 36 |
Effects of pioglitazone on mnemonic hippocampal function: A blood oxygen level–dependent functional magnetic resonance imaging study in elderly adults
|
Knodt, Annchen R.
|
|
|
5 |
C |
p. 254-263
|
artikel
|
| 37 |
Effects of the dual orexin receptor antagonist DORA-22 on sleep in 5XFAD mice
|
Duncan, Marilyn J.
|
|
|
5 |
C |
p. 70-80
|
artikel
|
| 38 |
Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease
|
Ballard, Clive
|
|
|
5 |
C |
p. 164-174
|
artikel
|
| 39 |
Estrogen activates Alzheimer's disease genes
|
Ratnakumar, Abhirami
|
|
|
5 |
C |
p. 906-917
|
artikel
|
| 40 |
Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease
|
Scheltens, Nienke M.E.
|
|
|
5 |
C |
p. 492-500
|
artikel
|
| 41 |
FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry”
|
Sabbagh, Marwan N.
|
|
|
5 |
C |
p. 13-19
|
artikel
|
| 42 |
Feasibility of an at-home, web-based, interactive exercise program for older adults
|
Feng, Nicole C.
|
|
|
5 |
C |
p. 825-833
|
artikel
|
| 43 |
Focused transcranial ultrasound for treatment of neurodegenerative dementia
|
Nicodemus, Natalie Eleanor
|
|
|
5 |
C |
p. 374-381
|
artikel
|
| 44 |
Forecasting the progression of Alzheimer's disease using neural networks and a novel preprocessing algorithm
|
Albright, Jack
|
|
|
5 |
C |
p. 483-491
|
artikel
|
| 45 |
From brain collections to modern brain banks: A historical perspective
|
Carlos, Arenn Faye
|
|
|
5 |
C |
p. 52-60
|
artikel
|
| 46 |
Ganglion cell layer thinning in prodromal Alzheimer's disease defined by amyloid PET
|
López-de-Eguileta, Alicia
|
|
|
5 |
C |
p. 570-578
|
artikel
|
| 47 |
General and domain-specific cognitive reserve, mild cognitive impairment, and dementia risk in older women
|
Petkus, Andrew J.
|
|
|
5 |
C |
p. 118-128
|
artikel
|
| 48 |
Hematologic safety of chronic brain-penetrating erythropoietin dosing in APP/PS1 mice
|
Sun, Jiahong
|
|
|
5 |
C |
p. 627-636
|
artikel
|
| 49 |
Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study
|
Yagi, Takuya
|
|
|
5 |
C |
p. 364-373
|
artikel
|
| 50 |
Ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer's disease
|
Fessel, Jeffrey
|
|
|
5 |
C |
p. 899-905
|
artikel
|
| 51 |
Institutionalization risk and costs associated with agitation in Alzheimer's disease
|
Cloutier, Martin
|
|
|
5 |
C |
p. 851-861
|
artikel
|
| 52 |
In vitro degradation of β-amyloid fibrils by microbial keratinase
|
Ningthoujam, Debananda S.
|
|
|
5 |
C |
p. 154-163
|
artikel
|
| 53 |
Key factors for the assessment of mobility in advanced dementia: A consensus approach
|
Van Ooteghem, Karen
|
|
|
5 |
C |
p. 409-419
|
artikel
|
| 54 |
Kinect Project: People with dementia or mild cognitive impairment learning to play group motion-based games
|
Dove, Erica
|
|
|
5 |
C |
p. 475-482
|
artikel
|
| 55 |
Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease
|
Villeneuve, Sarah-Christine
|
|
|
5 |
C |
p. 553-562
|
artikel
|
| 56 |
Linking the low-density lipoprotein receptor-binding segment enables the therapeutic 5-YHEDA peptide to cross the blood-brain barrier and scavenge excess iron and radicals in the brain of senescent mice
|
Zou, Zhenyou
|
|
|
5 |
C |
p. 717-731
|
artikel
|
| 57 |
Longitudinal analysis of risk factors for dementia based on Mild Cognitive Impairment Screen results and questionnaire responses from healthy Japanese individuals registered in an online database
|
Ogawa, Masayo
|
|
|
5 |
C |
p. 347-353
|
artikel
|
| 58 |
Machine learning models to predict onset of dementia: A label learning approach
|
Nori, Vijay S.
|
|
|
5 |
C |
p. 918-925
|
artikel
|
| 59 |
Magnetic resonance imaging measures of brain atrophy from the EXPEDITION3 trial in mild Alzheimer's disease
|
Schwarz, Adam J.
|
|
|
5 |
C |
p. 328-337
|
artikel
|
| 60 |
Memory matters in dementia: Efficacy of a mobile reminiscing therapy app
|
Yu, Fang
|
|
|
5 |
C |
p. 644-651
|
artikel
|
| 61 |
Moderate- to high-intensity exercise does not modify cortical β-amyloid in Alzheimer's disease
|
Frederiksen, Kristian S.
|
|
|
5 |
C |
p. 208-215
|
artikel
|
| 62 |
Neuropsychiatric symptoms in patients with dementia and the longitudinal costs of informal care in the Cache County population
|
Rattinger, Gail B.
|
|
|
5 |
C |
p. 81-88
|
artikel
|
| 63 |
New insight into Alzheimer's disease: Light reverses Aβ-obstructed interstitial fluid flow and ameliorates memory decline in APP/PS1 mice
|
Yue, Xiangpei
|
|
|
5 |
C |
p. 671-684
|
artikel
|
| 64 |
NGP 555, a γ-secretase modulator, shows a beneficial shift in the ratio of amyloid biomarkers in human cerebrospinal fluid at safe doses
|
Kounnas, Maria Z.
|
|
|
5 |
C |
p. 458-467
|
artikel
|
| 65 |
No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model
|
Baakman, Anne Catrien
|
|
|
5 |
C |
p. 89-98
|
artikel
|
| 66 |
Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise
|
Jensen, Camilla Steen
|
|
|
5 |
C |
p. 99-106
|
artikel
|
| 67 |
Perceptions of precision medicine among diverse dementia caregivers and professional providers
|
Gaugler, Joseph E.
|
|
|
5 |
C |
p. 468-474
|
artikel
|
| 68 |
Persistence and adherence to rivastigmine in patients with dementia: Results from a noninterventional, retrospective study using the National Health Insurance research database of Taiwan
|
Chang, Chee-Jen
|
|
|
5 |
C |
p. 46-51
|
artikel
|
| 69 |
Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016
|
Shimada, Yuki
|
|
|
5 |
C |
p. 228-230
|
artikel
|
| 70 |
Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress
|
Boada, Mercè
|
|
|
5 |
C |
p. 61-69
|
artikel
|
| 71 |
Plasmalogen deficiency and neuropathology in Alzheimer's disease: Causation or coincidence?
|
Senanayake, Vijitha
|
|
|
5 |
C |
p. 524-532
|
artikel
|
| 72 |
Pregnancy loss and risk of later dementia: A nationwide cohort study, Denmark, 1977–2017
|
Basit, Saima
|
|
|
5 |
C |
p. 146-153
|
artikel
|
| 73 |
Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs
|
Fessel, Jeffrey
|
|
|
5 |
C |
p. 780-788
|
artikel
|
| 74 |
Promising results from a pilot study to reduce distress in Vietnamese American dementia and memory loss caregivers
|
Ta Park, Van M.
|
|
|
5 |
C |
p. 319-327
|
artikel
|
| 75 |
Racial disparities and temporal trends in dementia misdiagnosis risk in the United States
|
Gianattasio, Kan Z.
|
|
|
5 |
C |
p. 891-898
|
artikel
|
| 76 |
Rates of lobar atrophy in asymptomatic MAPT mutation carriers
|
Chen, Qin
|
|
|
5 |
C |
p. 338-346
|
artikel
|
| 77 |
Reconsidering frameworks of Alzheimer's dementia when assessing psychosocial outcomes
|
Gaugler, Joseph E.
|
|
|
5 |
C |
p. 388-397
|
artikel
|
| 78 |
Recruitment and retention of underrepresented populations in Alzheimer's disease research: A systematic review
|
Gilmore-Bykovskyi, Andrea L.
|
|
|
5 |
C |
p. 751-770
|
artikel
|
| 79 |
Sex-specific composite scales for longitudinal studies of incipient Alzheimer’s disease
|
Banks, Sarah J.
|
|
|
5 |
C |
p. 508-514
|
artikel
|
| 80 |
Statistical methods for dementia risk prediction and recommendations for future work: A systematic review
|
Goerdten, Jantje
|
|
|
5 |
C |
p. 563-569
|
artikel
|
| 81 |
Study protocol of the self-monitoring activity program: Effects of activity on incident dementia
|
Shimada, Hiroyuki
|
|
|
5 |
C |
p. 303-307
|
artikel
|
| 82 |
Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
|
Galasko, Douglas
|
|
|
5 |
C |
p. 871-882
|
artikel
|
| 83 |
Tackling gaps in developing life-changing treatments for dementia
|
Mauricio, Rui
|
|
|
5 |
C |
p. 241-253
|
artikel
|
| 84 |
Telomere length associations with cognition depend on Alzheimer's disease biomarkers
|
Mahoney, Emily R.
|
|
|
5 |
C |
p. 883-890
|
artikel
|
| 85 |
Temporal association of neuropsychological test performance using unsupervised learning reveals a distinct signature of Alzheimer's disease status
|
Joshi, Prajakta S.
|
|
|
5 |
C |
p. 964-973
|
artikel
|
| 86 |
The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial
|
Chen, Christopher L.H.
|
|
|
5 |
C |
p. 38-45
|
artikel
|
| 87 |
The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease
|
Lopez Lopez, Cristina
|
|
|
5 |
C |
p. 216-227
|
artikel
|
| 88 |
The Brain Health Champion study: Health coaching changes behaviors in patients with cognitive impairment
|
Schwartz, Hope E.M.
|
|
|
5 |
C |
p. 771-779
|
artikel
|
| 89 |
The case-finding study: A novel community-based research recruitment approach for engaging participants with early cognitive decline
|
Dubé, Joseph B.
|
|
|
5 |
C |
p. 501-507
|
artikel
|
| 90 |
The cross-sectional association of cognitive stimulation factors and cognitive function among Latino adults in Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
|
Vásquez, Priscilla M.
|
|
|
5 |
C |
p. 533-541
|
artikel
|
| 91 |
The effects of information and communication technologies on informal caregivers of persons living with dementia: A systematic review
|
Lucero, Robert J.
|
|
|
5 |
C |
p. 1-12
|
artikel
|
| 92 |
The protective effects of polyphenols on Alzheimer's disease: A systematic review
|
Colizzi, Chiara
|
|
|
5 |
C |
p. 184-196
|
artikel
|
| 93 |
The relative efficiency of time-to-progression and continuous measures of cognition in presymptomatic Alzheimer's disease
|
Li, Dan
|
|
|
5 |
C |
p. 308-318
|
artikel
|
| 94 |
The role of acetylcholinesterase inhibitors such as neostigmine and rivastigmine on chronic pain and cognitive function in aging: A review of recent clinical applications
|
Eldufani, Jabril
|
|
|
5 |
C |
p. 175-183
|
artikel
|
| 95 |
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders
|
Alcolea, Daniel
|
|
|
5 |
C |
p. 597-609
|
artikel
|
| 96 |
The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial
|
Burns, Daniel K.
|
|
|
5 |
C |
p. 661-670
|
artikel
|
| 97 |
Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease
|
Wang, Guoqiao
|
|
|
5 |
C |
p. 450-457
|
artikel
|
| 98 |
Use and costs of services and unpaid care for people with mild-to-moderate dementia: Baseline results from the IDEAL cohort study
|
Henderson, Catherine
|
|
|
5 |
C |
p. 685-696
|
artikel
|
| 99 |
Using data science to diagnose and characterize heterogeneity of Alzheimer's disease
|
Ang, Ting F.A.
|
|
|
5 |
C |
p. 264-271
|
artikel
|
| 100 |
Vascular contributions to cognitive impairment and dementia: Research consortia that focus on etiology and treatable targets to lessen the burden of dementia worldwide
|
Gladman, Jordan T.
|
|
|
5 |
C |
p. 789-796
|
artikel
|
| 101 |
Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images
|
Sharafi, Sayed Mehran
|
|
|
5 |
C |
p. 610-617
|
artikel
|
| 102 |
White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities
|
Alber, Jessica
|
|
|
5 |
C |
p. 107-117
|
artikel
|
Tijdschrift beschrijving